Exceptional response to olaparib in BRCA2 -altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure
Necchi, Andrea, Raggi, Daniele, Giannatempo, Patrizia, Alessi, Alessandra, Serafini, Gianluca, Colecchia, Maurizio, Ali, Siraj M., Chung, Jon H.Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2018.03.021
Date:
April, 2018
File:
PDF, 1.22 MB
english, 2018